Mineralocorticoid Receptor Antagonism Attenuates Multiple Organ Failure after Renal Ischemia and Reperfusion in Mice
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043413 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Eun Jung Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Republic of Korea. Hauptthemen laut MEDLINE: Acute Kidney Injury, Reperfusion Injury. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT and Future Planning.
Abstract (Originalsprache)
Renal ischemia reperfusion (IR) injury is a major cause of acute kidney injury (AKI) that is often complicated by multiple organ failure of the liver and intestine. The mineralocorticoid receptor (MR) is activated in patients with renal failure associated with glomerular and tubular damage. We thus investigated whether canrenoic acid (CA), a mineralocorticoid receptor (MR) antagonist, protects against AKI-induced hepatic and intestinal injury, suggesting the underlying mechanisms. Mice were divided into five groups: sham mice, mice subjected to renal IR, and mice pretreated with canrenoic acid (CA; 1 or 10 mg/kg) 30 min prior to renal IR. At 24 h after renal IR, the levels of plasma creatinine, alanine aminotransferase and aldosterone were measured, and structural changes and inflammatory responses of the kidney, liver, and intestine were analyzed. We found that CA treatment reduced plasma creatinine levels, tubular cell death and oxidative stress induced by renal IR. CA treatment also decreased renal neutrophil infiltration and inflammatory cytokine expression and inhibited the release of high-mobility group box 1 induced by renal IR. Consistently, CA treatment reduced renal IR-induced plasma alanine transaminase, hepatocellular injury and neutrophil infiltration, and inflammatory cytokine expression. CA treatment also decreased small intestinal cell death, neutrophil infiltration and inflammatory cytokine expression induced by renal IR. Taken together, we conclude that MR antagonism by CA treatment protects against multiple organ failure in the liver and intestine after renal IR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Republic of Korea.
- Department of Convergence Medical Sciences, Gyeongsang National University Graduate School, Jinju 52727, Republic of Korea.
ORCID-Profile: Theodomir Dusabimana, Hwajin Kim, Sang Won Park
Förderung
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Park, E. J., Je, J., Dusabimana, T., Yun, S. P., Kim, H. J., Kim, H., & Park, S. W. (2023). Mineralocorticoid Receptor Antagonism Attenuates Multiple Organ Failure after Renal Ischemia and Reperfusion in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043413
Vancouver
Park EJ, Je J, Dusabimana T, Yun SP, Kim HJ, Kim H, et al. Mineralocorticoid Receptor Antagonism Attenuates Multiple Organ Failure after Renal Ischemia and Reperfusion in Mice. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043413
BibTeX
@article{Park2023,
author = {Park, Eun Jung and Je, Jihyun and Dusabimana, Theodomir and Yun, Seung Pil and Kim, Hye Jung and Kim, Hwajin and Park, Sang Won},
title = {Mineralocorticoid Receptor Antagonism Attenuates Multiple Organ Failure after Renal Ischemia and Reperfusion in Mice},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043413}
}
EUVIMED